Sovilnesib not checked
Volastra Therapeutics, Inc. · AMG 650
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- Tested for
- High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Chromosomal Instability
- Main trialPhase 1
- “This is a phase 1b study to assess the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of sovilnesib at different dose levels to establish the optimal dose of sovilnesib in subjects with selected advanced solid tumors.”In the company’s words, NCT06084416 on ClinicalTrials.gov
- Other names
- AMG 650
Other drugs for High Grade Serous Adenocarcinoma of Ovary
- Mirvetuximab soravtansineAbbVie · Phase 3
- OregovomabCanariaBio Inc. · Phase 3
- JSKN003Alphamab · JMT-Bio · Phase 3
- Olvimulogene nanivacirepvecGenelux GmbH · Phase 3
- IMNN-001Imunon · Phase 3
- Izalontamab brengitecanSichuan Baili (Biokin, SystImmune) · Bristol Myers Squibb · Phase 3
Coming up1
- Nov 2027Phase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Recruiting | Nov 2027 | A Study of Sovilnesib in Subjects With Ovarian Cancer | |
| Phase 1Completed | 24 Oct 2022 | Study of AMG 650 in Adult Participants With Advanced Solid Tumors |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026